New research confirms what you already knew—or at least suspected: Female veterinarians earn less than their male counterparts.
Each month in NEWStat, we highlight an article from the upcoming issue of Trends magazine. The most important thing to know about cannabis in veterinary medicine is that things continue to change. By waiting for a definitive decree from national or state organizations or accepting prior statements as final, veterinarians may find themselves far behind in their knowledge of how cannabis-derived products such as cannabidiol (CBD) affect patients’ lives. Saying nothing may no longer be viable.
This week: The lab animals most likely to lead to a coronavirus vaccine, and why you shouldn’t believe everything you hear about stray dogs and coronavirus. Plus, is pet grooming an “essential” service?
This month, AAHA and the AVMA released the 2021 AAHA/AVMA Telehealth Guidelines for Small-Animal Practice , a step-by-step roadmap for how to incorporate telehealth effectively and efficiently into veterinary practices.
David Ballard, PsyD, MBA, our guest on this week’s episode of Central Line: The AAHA Podcast , is not just a visionary – he's an expert in what makes organizations psychologically healthy, and he’s helped groups all over the human healthcare ecosystem get there. Thanks to connections that led him to Veterinary Visionaries, he’s turning that expert eye toward veterinary medicine. Check out this excerpt from our conversation.
We face an unbelievable scenario in the United States with the treatment of feline infectious peritonitis (FIP) , where our only option is to suggest clients meet up with strangers in parking lots to buy an unapproved medication to inject into their dying cats .
A new study offers hope for treating hemangiosarcoma, the “silent killer” that often isn’t diagnosed until a seemingly healthy dog suffers from acute collapse due to a ruptured, bleeding tumor, usually on the spleen.
Bexacat is the first oral drug treatment of diabetes in cats and offers an alternative to insulin injections—but veterinarians must choose the right patients due to important safety considerations.
Surgery to treat herniated discs in dogs can cost up to $12,000 and result in weeks of painful recovery for the patient . A clinical trial at Texas A&M is testing a nonsurgical outpatient treatment that is far less expensive and less invasive.
Nearly 40% of dogs show signs of canine osteoarthritis (OA), but many don’t receive treatment. That could change with the newly FDA-approved Librela, a monthly injectable that has been used by veterinarians in Europe for the past two years with largely positive results.